Status: Recruiting
No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kafrelsheikh UniversityUpdated: May 13, 2025Locations: 1
Eligibility criteria
Age ≥ 18 years old. [+2]
Treatment with thrombolytic drugs in the previous 24 hours. [+6]